Target intelligence / Profile preview

Ion channels and membrane proteins

Molecular classification
Ion channel, Transporter, Receptor, Enzyme
01

Overview

Ion channels and membrane proteins represent a broad category of biological molecules that reside within the lipid bilayer of cells and organelles, serving as the primary interface between the cell and its environment (Santos et al., 2017, Nature Reviews Drug Discovery). This group includes voltage-gated and ligand-gated ion channels, G protein-coupled receptors (GPCRs), and various solute carriers and ATP-dependent transporters (Overington et al., 2006, Nature Reviews Drug Discovery). They are essential for maintaining cellular homeostasis, generating action potentials in excitable tissues, and facilitating the transport of nutrients and waste (Bagal et al., 2013, Journal of Medicinal Chemistry). Due to their critical physiological roles and accessibility to extracellular drugs, they account for approximately 60% of all current therapeutic targets (Santos et al., 2017). Dysfunctions in these proteins are implicated in a wide range of pathologies, including cardiac arrhythmias, epilepsy, cystic fibrosis, and various cancers (StatPearls, 2023, Ion Channels). Pharmacological agents targeting these proteins include a diverse array of small molecules and biologics that modulate their activity to treat chronic and acute conditions.

Other names
Integral membrane proteinsTransmembrane proteinsSurface proteinsMembrane-bound proteins
02

Mechanism of action

Drugs targeting these proteins typically act as pore blockers, allosteric modulators, competitive antagonists, or agonists to regulate the movement of ions and molecules or to initiate intracellular signaling cascades.

03

Biological functions

Signal transductionIon transportCell-cell communicationMetabolic transportMaintenance of electrochemical gradients
04

Disease associations

ChannelopathyCancerNeurological disorderCardiovascular diseaseCystic fibrosisMetabolic syndrome
05

Safety considerations

QT interval prolongationOff-target toxicity due to widespread expressionBlood-brain barrier permeability issuesElectrolyte imbalances
06

Interacting drugs

Lidocaine

5 more in the full profile.

07

Biomarkers

hERG inhibition (safety)Serum electrolyte levelsTarget protein expression via immunohistochemistryIon current density

Beyond the preview

Go deeper on Ion channels and membrane proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ion channels and membrane proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call